Posts

Renewable Energy Market Size, Share, Growth, and Forecast 2032 : BAMG Consulting

Renewable Energy Market Worth $4.9 Billion By 2032, Driven by Declining Technology Costs, Government Clean Energy Policies and Rising Demand for Sustainable Power- New Report by BMAG Consulting New Delhi, India – September 13, 2026: BMAG Consulting, a global market research and strategic advisory firm, has published its latest report titled " Renewable Energy ", offering a comprehensive assessment of market dynamics, growth drivers, segmentation trends, regional outlook, and the competitive landscape. According to the report, the global renewable energy market was valued at USD 1.9 billion in 2024 and is expected to reach USD 4.9 billion by 2032, registering a compound annual growth rate (CAGR) of 14.7% during the forecast period 2025–2032. The renewable energy market is growing due to increasing global awareness of carbon emissions, declining costs of solar and wind technologies, supportive government policies, and rising demand for low-carbon electricity. The accelerating i...

Biopharmaceutical Market Size, Share, Growth, and Forecast 2032 : BAMG Consulting

Biopharmaceutical Market to Reach USD 848.6 Billion by 2032, Driven by Biologics, Monoclonal Antibodies, AI-Powered Drug Discovery & Advanced Therapies – New Report by BMAG Consulting New Delhi, India – September 10, 2026: BMAG Consulting, a leading market intelligence and consulting firm, has released its latest Biopharmaceutical Market research report, providing comprehensive insights into market size, growth trends, biologic drug development, emerging technologies, therapeutic applications, competitive dynamics, regional opportunities, and industry developments through 2032. The global biopharmaceutical market was valued at USD 453.7 billion in 2025 and is projected to reach USD 848.6 billion by 2032 , expanding at a CAGR of 8.2% during 2025–2032 . Market expansion is being supported by the rising prevalence of chronic and rare diseases, growing adoption of biologic therapies, advances in antibody engineering, gene editing and mRNA technologies, increasing biosimilar develop...